Gene: PABPN1L
Official Full Name: PABPN1 like, cytoplasmicprovided by HGNC
Gene Summary: Predicted to enable poly(A) binding activity. Predicted to be involved in nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay. Predicted to act upstream of or within maternal-to-zygotic transition of gene expression; negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process; and negative regulation of protein ubiquitination. Predicted to be located in cytoplasm. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA02488 | PABPN1L Knockout cell line (AC16) | Human | PABPN1L | 1:3-1:4 | negative | Online Inquiry |
| KOA17934 | PABPN1L Knockout cell line (BEAS-2B) | Human | PABPN1L | 1:3~1:4 | negative | Online Inquiry |
| KOA33383 | PABPN1L Knockout cell line (U-2932) | Human | PABPN1L | 1:2-1:4 | negative | Online Inquiry |
| KOA48791 | PABPN1L Knockout cell line (TPC-1) | Human | PABPN1L | 1:5-1:8 | negative | Online Inquiry |
| KOA64191 | PABPN1L Knockout cell line (NCM460) | Human | PABPN1L | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.